Search Results - "Salomon, Hervé"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients by Lemieux, Isabelle, Salomon, Hervé, Després, Jean-Pierre

    Published in Annals of medicine (Helsinki) (2003)
    “…Apolipoprotein (apo) CIII plays an important role in the catabolism of triglyceride-rich lipoproteins as it is a potent inhibitor of lipoprotein lipase (LPL)…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Safety and immunogenicity of a recombinant HIV type 1 glycoprotein 160 boosted by a V3 synthetic peptide in HIV-negative volunteers by Salmon-Céron, D, Excler, J L, Sicard, D, Blanche, P, Finkielstzjen, L, Gluckman, J C, Autran, B, Matthews, T J, Meignier, B, Kieny, M P

    Published in AIDS research and human retroviruses (01-12-1995)
    “…The safety and the immunogenicity of a recombinant hybrid envelope glycoprotein MN/LAI (rgp160) followed by booster injections of a V3 (MN) linear peptide were…”
    Get more information
    Journal Article
  7. 7

    Comparison of Micronized Fenofibrate and Pravastatin in Patients With Primary Hyperlipidemia by Ducobu, Jean, VanHaelst, Luc, Salomon, Herve

    Published in Journal of cardiovascular pharmacology (01-01-2003)
    “…Micronized fenofibrate lowers total cholesterol and low-density lipoprotein cholesterol to a similar extent as statins but raises high-density lipoprotein…”
    Get full text
    Journal Article